Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPC vs GP Induction for High-Risk NPC
NCT06301165Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Mar 2024; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT06301165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301165.